The global industrial computed radiography market is estimated to reach $68.8 million in 2033 from $59.1 million in 2022, at a growth rate of 1.49% during the forecast period 2023-2033. The growth in the industrial computed radiography system market is expected to be driven by the evolution of Industry 4.0 practices and an increase in the need for portable radiography systems.

Market Lifecycle Stage

Conventionally, the industrial non-destructive radiography inspection methods are carried out using the conventional X-Ray machine that uses film to capture images of the defects, and the technicians identify the defects from the film manually. This method consumed huge time to capture the image and required skilled laborers to operate the equipment and identify images.

In addition, it requires a huge storage facility to store the films. So, the radiography solution manufacturers developed an upgraded version of conventional X-Ray solutions known as industrial computed radiography.

The industrial computed radiography solutions help the technician to capture the image using an imaging plate and convert the image into a digital format using a computed radiography (CR) reader. This reduced the time of capturing the image and helped to visualize the defects digitally using the review station and acquisition software.

Furthermore, it helps to save the image of the defects digitally, which requires the cost spent on storage facilities and can be shared with clients easily.

One of the major factors attributing to the demand of industrial computed radiography solution is the rising demand from the commercial aviation industry, which is driven by the order backlog for next-generation commercial aircraft that is expected to be built.

Impact

The global industrial computed radiography market is observing steady growth, which is expected to drive investments and partnerships across computed radiography technology. The major challenge in the industrial computed radiography market is there is lack of skilled laborers to conduct non-destructive testing using computed radiography systems.

In addition, the growth of the digital radiography system increases the demand for real-time image visualization and automatic defect identification technology. This leads the developer to move toward the digital radiography system, which affects the growth of industrial computed radiography systems in the market.

In addition, the oil and gas and aerospace industries are looking for a more compact and portable radiography system that offers real-time image visualization even offshore to rectify the defect quickly and efficiently. Therefore, non-destructive testing service providers and industrial computed radiography system manufacturers are gradually moving toward digital radiography systems from computed radiography systems.

Market Segmentation

Segmentation 1: by Application

• Aerospace and Defense
• Automotive
• Oil and Gas
• Power and Energy
• Security
• Explosive Ordnance Disposal and Improvised Explosive Device
• Electronics and Semiconductors
• Food and Drugs
• Transportation Infrastructure
• Construction
• Marine
• Manufacturing
• Heavy Industries
• Others

Among all these applications, aerospace and defense and oil and gas are expected to dominate the market.

Segmentation 2: by Component

• Imaging Plates
• Computed Radiography Reader (Digitizer)
• Review Station with Acquisition Software

Based on components, imaging plates are expected to dominate in terms of volume as they are the major consumable in the industrial computed radiography market and are usually replaced after certain intervals.

Segmentation 3: by Region

• North America – U.S. and Canada
• Europe – France, Germany, Russia, U.K, and Rest-of-Europe
• Asia-Pacific – China, Japan, India, and Rest-of-Asia-Pacific
• Rest-of-the-World – Middle and Africa and Latin America

Based on region, the industrial computed radiography market is expected to be dominated by Europe, and in terms of country, the U.S. is expected to dominate during the forecast period.

Recent Developments in the Global Industrial Computed Radiography Market

• In September 2022, DÜRR NDT GmbH & Co. KG partnered with JME Ltd. to develop an innovative X-Ray solution. The partnership would help JME Ltd. to utilize the D-Tect X software with the DXB:1 to inspect circumferential welds in applications such as new pipelines.

• In July 2022, L3Harris Technologies partnered with DÜRR NDT GmbH & Co. KG to utilize ScanX Discover HC computed radiography scanner to electronically capture X-Ray images and then project them digitally on a monitor for evaluation.

• In February 2021, DÜRR NDT GmbH & Co. KG launched a new D-Tect X NDT software, which offers high performance, is user-friendly, and is extremely flexible.

• In November 2019, Rigaku Corporation extended its partnership with Covalent Metrology to install two of its new analytical instruments in the new facility of Covalent Metrology located in Sunnyvale, California.

• In June 2018, Carestream Health partnered with ayData Management, LLC to offer customers integrated DICONDE-based archive storage solutions worldwide. By utilizing the ayData Management NDT archiving suite of products, Carestream’s NDT would be able to enhance its end-to-end digital product line.

Demand – Drivers and Limitations

The following are the drivers for the global industrial computed radiography market:

• Emerging Demand from the Aerospace and Defense Industry
• Rising Demand for Computed Radiography Due to the Evolution of Industry 4.0 Practices
• Rising Demand for Portable Computed Radiography

The following are the challenges for the global industrial computed radiography market:

• Lack of Skilled Labors
• Increasing Demand for Real-Time Image Visualization

The following are the opportunities for the global industrial computed radiography market:

• Persisting Need for CR Capabilities in Oil and Gas Domain
• Opportunities in the Aviation/MRO Domain
• Opportunities in Providing NDT Certification to Technician

How can this report add value to an organization?

Platform/Innovation Strategy: The product segment helps the reader understand the various component that is integrated with industrial computed radiography to conduct safe, secure, and efficient non-destructive testing. Moreover, the study provides the reader with a detailed understanding of the components, such as imaging plates and computed radiography readers. In addition, it provides a detailed understanding of the acquisition software that the review station uses to review the images captured by the imaging plates.

Growth/Marketing Strategy: The global industrial computed radiography market has seen major development activities by key players operating in the market, such as business expansion activities, contracts, mergers, partnerships, collaborations, and joint ventures.

The favored strategy for the companies has been contracted to strengthen their position in the industrial computed radiography market. For instance, in September 2022, DÜRR NDT GmbH & Co. KG partnered with JME Ltd. to develop an innovative X-Ray solution.

The partnership would help JME Ltd. to utilize the D-Tect X software with the DXB:1 to inspect circumferential welds in applications such as new pipelines. Furthermore, in July 2022, L3Harris Technologies partnered with DÜRR NDT GmbH & Co. KG to utilize ScanX Discover HC computed radiography scanner to electronically capture X-Ray images and then project them digitally on a monitor for evaluation.

Competitive Strategy: Key players in the global industrial computed radiography market analyzed and profiled in the study involve industrial computed radiography manufacturers that offer docking systems and enabling capabilities.

Moreover, a detailed competitive benchmarking of the players operating in the global industrial computed radiography market offers various solutions to conduct non-destructive testing efficiently through portable computed radiography systems.

Additionally, comprehensive competitive strategies such as contracts, partnerships, agreements, acquisitions, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysis of the company’s coverage, product portfolio, and market penetration.

In 2022, the top segment players leading the market included established players manufacturing industrial computed radiography, constituting 100% of the presence in the market. Since it is an established product, the industrial computed radiography market doesn’t have startups.

Key Companies Profiled

• Carestream Health
• DÜRR NDT GmbH & Co. KG
• FUJIFILM Holdings America Corporation
• L3Harris Technologies, Inc.
• MQS Technologies Pvt. Ltd.
• Rigaku Corporation
• Virtual Media Integration
• Waygate Technologies (Baker Hughes Company)

The post Industrial Computed Radiography Market – A Global and Regional Analysis: Focus on Application, Components, and Country – Analysis and Forecast, 2023-2033 first appeared on CRI Report.

The global castor oil-based biopolymer market is projected to reach $3,320.9 million by 2031 from $741.3 million in 2021, growing at a CAGR of 16.7% during the forecast period 2022-2031.

The demand for castor oil-based biopolymers is anticipated to grow with the increasing adoption of bio-polyamides from end-user industries such as automotive, household appliances, oil and gas, and others.

Furthermore, it is anticipated that during the projected period (2022-2031), the increasing adoption of high-performance bio-polyamides in the automotive industry and growing usage of sustainable biopolymers in sports accessories, such as helmets and shoes, are expected to further fuel the advancement of the global castor oil-based biopolymer market.

The advanced characteristics of castor oil-based biopolymers, such as easy processing, chemical resistance, toughness, dimensional stability, and abrasion resistance, support their adoption by a wide range of end users.

However, the high cost of castor oil-based biopolymers, frequent fluctuating raw material prices, and dependency on India as only one major castor seed supplier is anticipated to hinder market growth in the upcoming future.

Market Lifecycle Stage

The global castor oil-based biopolymer market is in the growth phase. The rising awareness about biopolymers across the globe, along with stringent government regulations pertaining to supporting a carbon-neutral economy, is expected to drive the demand for sustainable biopolymer solutions.

Additionally, growing research and development activities, along with rising investments, are expected to boost market innovations. The adoption of bio-polyamides in various apparel brands is gaining momentum owing to superior characteristics such as extremely breathable, ultra-light, and super stretch product.

Moreover, the global castor oil-based biopolymer market is expected to benefit from the growing household appliances industry in developing economies owing to rising disposable income and increasing number of nuclear families, among others.

Industrial Impact

Castor oil-based biopolymers continue to improve the toughness, chemical resistance, aesthetics, and durability of the materials to which they are applied. As a result, castor oil-based biopolymer materials are gaining importance in a variety of end users, including heavy commercial automotives, household appliances, and textiles, among others.

One area where the adoption of castor oil-based biopolymer has been rising at a considerable pace is the automotive industry, as castor oil-based biopolymer auto parts are lightweight, thereby enhancing fuel efficiency and minimizing carbon emission. This is expected to create opportunities for both existing market participants and market entrants.

Furthermore, castor oil-based biopolymers have a moderate to high impact on end-user industries; however, in the upcoming future, with increased adoption of high-end household appliances, sustainable textiles, rising automotive production, and other applications, the impact is anticipated to increase.

Impact of COVID-19

COVID-19 had a considerable impact on the global castor oil-based biopolymer market owing to country-wide lockdowns, labor shortages, temporary shutdown of manufacturing sites, and disruptions in supply chains globally. The lockdowns imposed by the governments significantly reduced automotive production, thereby further shown adverse impact on the market.

China is one of the major consumers of castor oil-based biopolymer and zero covid policy adopted by the country has shown sever adverse impact on raw material supply chain. The global demand for castor oil-based biopolymers have been adversely impacted by these downturns in the end-user industries. However, the market is expected to recover with growing automotive industry gradually over the forecast period.

Market Segmentation

Segmentation 1: by End User

• Automotive
• Solar
• Household Appliances
• Textile
• Oil and Gas
• Others

Based on the end user, the automotive segment dominated the castor oil-based biopolymer market in 2021 and is expected to showcase considerable growth, owing to rising sales of passenger cars across the globe.

Segmentation 2: by Polymer Type

• Bio-Polyamides
o Bio-Polyamide 6
o Bio-Polyamide 10 and 11
• Bio-Polyurethane
• Others

Among different polymer types, bio-polyamides are anticipated to lead the market during the forecast period (2022-2031).

Segmentation 3: by Form

• Pellets
• Yarns
• Others

The global castor oil-based biopolymer market is estimated to be led by pellets in terms of form.

Segmentation 4: by Region

• North America – U.S., Canada, and Mexico
• Europe – Germany, France, Italy, Spain, and Rest-of-Europe
• U.K.
• China
• Asia-Pacific and Japan – Japan, South Korea, India, and Rest-of-Asia-Pacific
• Rest-of-the-World – Middle East and Africa and South America

In the global castor oil-based biopolymer market, China and Asia-Pacific and Japan are estimated to gain traction in castor oil-based biopolymer production, owing to the continuous growth in automotive production and the presence of key manufacturers in the regions.

Recent Developments in the Global Castor Oil-Based Biopolymer Market

• In October 2022, Toray Industries, Inc. developed “Ultrasuede nu,” a polyester-based headrest cover. The cover is made up of three structures, including ultra-fine fibers, elastomer, and scrim. The elastomer is composed of castor oil-based polyurethane material. With the launch of Ultrasuede nu material, the company is focusing on the development of eco-conscious products and thereby enhancing its capabilities in a sustainable ecosystem.
• In January 2022, Toray Industries, Inc. announced the commercialization of nylon grade (N510) fiber, developed with the usage of 100% plant-based fiber. The product is predominantly used for athletic and outdoor fabrics, which also include compact snip textiles and embroidered components for garments.
• In October 2021, Arkema announced the establishment of a new bio-based polyamide 11 powder plant in China. The plant will commence production in the first quarter of 2023. The rising adoption of biopolymers in 3D printing and the company’s strategic partnership with HP are expected to drive the demand for polyamide 11 powder over the forecast period.

Demand – Drivers and Limitations

Following are the demand drivers for the global castor oil-based biopolymer market:

• Growing Automotive Industry across the Globe
• Rising Demand for High-Performance Polyamide Yarns in Textile Industry
• Advanced Chemical and Mechanical Properties of Castor Oil-Based Biopolymers

The market is expected to face some limitations as well due to the following challenges:

• Dependency Only on India for Crop Cultivation of Castor Beans
• High Cost and Rising Price Volatility of Raw Materials

How can this report add value to an organization?s

Product/Innovation Strategy: The product segment helps the reader understand the different polymer types involved in the production of castor oil-based biopolymers, such as bio-polyamides, bio-polyurethane, and others. Moreover, the study provides the reader with a detailed understanding of the global castor oil-based biopolymer market based on the end user (automotive, solar, household appliances, oil and gas, textile, and others). Castor oil-based biopolymers are gaining traction in end-user industries on the back of sustainability concerns and their excellent properties, such as lightweight, toughness, and chemical and abrasion resistance.

Growth/Marketing Strategy: The global castor oil-based biopolymer market has seen major development by key players operating in the market, such as the establishment of new production facilities, product development, mergers and acquisitions, and strategic joint ventures to strengthen their position in the global castor oil-based biopolymer market. For instance, in March 2022, Nexis Fibers showcased its semi-biobased polyamide filaments products made with 63% of castor oil. The product is showcased in Techtextil, an international trade fair for technical textiles and nonwovens.

Competitive Strategy: Key players in the global castor oil-based biopolymer market analyzed and profiled in the study involve castor oil-based biopolymer manufacturers and the overall ecosystem. Moreover, a detailed competitive benchmarking of the players operating in the global castor oil-based biopolymer market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as agreements, partnerships, acquisitions, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, and market penetration.

The global castor oil-based biopolymer market has been segmented by different polymer types, among which bio-polyamides captured around 98.28% of the market as of 2021. The bio-polyamides segment is further bifurcated into bio-polyamide 6 and bio-polyamide 10 & 11. The bio-polyamide 6 accounted for 10.81%, and bio-polyamide 10 and 11 accounted for 87.47%. Other polymer types, including bio-polyurethane, accounted for around 1.12%, and other polymer types accounted for 0.6% of the total demand in 2021 in terms of value.

Key Companies Profiled

• Arkema
• Evonik Industries AG
• BASF SE
• EMS-Chemie Holding AG
• Solvay S.A.
• Toray Industries, Inc.
• UNITIKA LTD.
• RadiciGroup
• Fulgar SpA
• DSM
• DuPont de Nemours, Inc.
• Mitsui Chemicals Inc.
• Nexis Fibers
• VAUDE Sport GmbH & Co. KG
• EOS GmbH
• AWAKE CONCEPT
• NEUBAU EYEWEAR gmbh
• Lanxess AG
• BIO-FED
• Asahi Kasei Corporation

Table of Contents

1 Markets
1.1 Industry Outlook
1.1.1 Trends: Current and Future
1.1.1.1 Growing Electronic Industry and Emerging Use of Castor Oil-Based Biopolymers
1.1.1.2 Growing Awareness about Sustainability and Biopolymers
1.1.2 Supply Chain Analysis
1.1.3 Ecosystem/Ongoing Programs
1.1.3.1 Consortiums and Associations
1.1.3.2 Regulatory Bodies
1.1.3.3 Government Programs
1.1.3.4 Programs by Research Institutions and Universities
1.1.4 Impact of COVID-19 on the Castor Oil-Based Biopolymer Market
1.2 Business Dynamics
1.2.1 Business Drivers
1.2.1.1 Growing Automotive Industry across the Globe
1.2.1.2 Rising Demand for High-Performance Polyamide Yarns in Textile Industry
1.2.1.3 Advanced Chemical and Mechanical Properties of Castor Oil-Based Biopolymers
1.2.2 Business Challenges
1.2.2.1 Dependency Only on India for Crop Cultivation of Castor Beans
1.2.2.2 High Cost and Rising Price Volatility of Raw Materials
1.2.3 Business Strategies
1.2.3.1 Product Developments
1.2.3.2 Market Developments
1.2.4 Business Opportunities
1.2.4.1 Emerging Additive Manufacturing Sector and Use of Castor Oil-Based Biopolymer Powders in 3D Printing
1.2.4.2 Emerging Self-Driving/Autonomous Vehicles Industry
1.3 Start-Up/Emerging Manufacturer Landscape
1.3.1 Key Start-Ups/Emerging Manufacturers in the Ecosystem

2 Application
2.1 Global Castor Oil-Based Biopolymer Market (Applications and Specifications)
2.1.1 Global Castor Oil-Based Biopolymer Market (by End User)
2.1.1.1 Automotive
2.1.1.2 Solar
2.1.1.3 Household Appliances
2.1.1.4 Textile
2.1.1.5 Oil and Gas
2.1.1.6 Others
2.2 Demand Analysis of Castor Oil-Based Biopolymer Market (by End User), Volume and Value Data

3 Products
3.1 Global Castor Oil-Based Biopolymer Market (Products and Specifications)
3.1.1 Global Castor Oil-Based Biopolymer Market (by Polymer Type)
3.1.1.1 Bio-Polyamides
3.1.1.1.1 Bio-Polyamide 6
3.1.1.1.2 Bio-Polyamide 10 and 11
3.1.1.2 Bio-Polyurethane
3.1.1.3 Others
3.2 Demand Analysis of Castor Oil-Based Biopolymer Market (by Polymer Type), Volume and Value Data
3.3 Global Castor Oil-Based Biopolymer Market (by Form)
3.3.1 Pellets
3.3.2 Yarns
3.3.3 Others
3.4 Demand Analysis of Castor Oil-Based Biopolymer Market (by Form), Volume and Value Data
3.5 Patent Analysis
3.5.1 Patent Analysis (by Organization)
3.6 Product Benchmarking: Growth Rate-Market Share Matrix, By Form, 2021
3.7 Castor Oil-Based Biopolymer Market: Average Pricing Analysis

4 Regions
4.1 North America
4.1.1 Market
4.1.1.1 Key Producers and Suppliers in North America
4.1.1.2 Business Drivers
4.1.1.3 Business Challenges
4.1.2 Applications
4.1.2.1 North America Castor Oil-Based Biopolymer Market (by End User), Volume and Value Data
4.1.3 Products
4.1.3.1 North America Castor Oil-Based Biopolymer Market (by Polymer Type), Volume and Value Data
4.1.3.2 North America Castor Oil-Based Biopolymer Market (by Form), Volume and Value Data
4.1.4 North America (by Country)
4.1.4.1 U.S.
4.1.4.1.1 Market
4.1.4.1.1.1 Buyer Attributes
4.1.4.1.1.2 Key Producers and Suppliers in the U.S.
4.1.4.1.1.3 Business Drivers
4.1.4.1.1.4 Business Challenges
4.1.4.1.2 Applications
4.1.4.1.2.1 U.S. Castor Oil-Based Biopolymer Market (by End User), Volume and Value Data
4.1.4.1.3 Products
4.1.4.1.3.1 U.S. Castor Oil-Based Biopolymer Market (by Polymer Type), Volume and Value Data
4.1.4.1.3.2 U.S. Castor Oil-Based Biopolymer Market (by Form), Volume and Value Data
4.1.4.2 Canada
4.1.4.2.1 Market
4.1.4.2.1.1 Buyer Attributes
4.1.4.2.1.2 Key Producers and Suppliers in Canada
4.1.4.2.1.3 Business Drivers
4.1.4.2.1.4 Business Challenges
4.1.4.2.2 Applications
4.1.4.2.2.1 Canada Castor Oil-Based Biopolymer Market (by End User), Volume and Value Data
4.1.4.2.3 Products
4.1.4.2.3.1 Canada Castor Oil-Based Biopolymer Market (by Polymer Type), Volume and Value Data
4.1.4.2.3.2 Canada Castor Oil-Based Biopolymer Market (by Form), Volume and Value Data
4.1.4.3 Mexico
4.1.4.3.1 Market
4.1.4.3.1.1 Buyer Attributes
4.1.4.3.1.2 Key Producers and Suppliers in Mexico
4.1.4.3.1.3 Business Drivers
4.1.4.3.1.4 Business Challenges
4.1.4.3.2 Applications
4.1.4.3.2.1 Mexico Castor Oil-Based Biopolymer Market (by End User), Volume and Value Data
4.1.4.3.3 Products
4.1.4.3.3.1 Mexico Castor Oil-Based Biopolymer Market (by Polymer Type), Volume and Value Data
4.1.4.3.3.2 Mexico Castor Oil-Based Biopolymer Market (by Form), Volume and Value Data
4.2 Europe
4.2.1 Market
4.2.1.1 Key Producers and Suppliers in Europe
4.2.1.2 Business Drivers
4.2.1.3 Business Challenges
4.2.2 Applications
4.2.2.1 Europe Castor Oil-Based Biopolymer Market (by End User), Volume and Value Data
4.2.3 Products
4.2.3.1 Europe Castor Oil-Based Biopolymer Market (by Polymer Type), Volume and Value Data
4.2.3.2 Europe Castor Oil-Based Biopolymer Market (by Form), Volume and Value Data
4.2.4 Europe (by Country)
4.2.4.1 Germany
4.2.4.1.1 Market
4.2.4.1.1.1 Buyer Attributes
4.2.4.1.1.2 Key Producers and Suppliers in Germany
4.2.4.1.1.3 Business Drivers
4.2.4.1.1.4 Business Challenges
4.2.4.1.2 Applications
4.2.4.1.2.1 Germany Castor Oil-Based Biopolymer Market (by End User), Volume and Value Data
4.2.4.1.3 Products
4.2.4.1.3.1 Germany Castor Oil-Based Biopolymer Market (by Polymer Type), Volume and Value Data
4.2.4.1.3.2 Germany Castor Oil-Based Biopolymer Market (by Form), Volume and Value Data
4.2.4.2 France
4.2.4.2.1 Market
4.2.4.2.1.1 Buyer Attributes
4.2.4.2.1.2 Key Producers and Suppliers in France
4.2.4.2.1.3 Business Drivers
4.2.4.2.1.4 Business Challenges
4.2.4.2.2 Applications
4.2.4.2.2.1 France Castor Oil-Based Biopolymer Market (by End User), Volume and Value Data
4.2.4.2.3 Products
4.2.4.2.3.1 France Castor Oil-Based Biopolymer Market (by Polymer Type), Volume and Value Data
4.2.4.2.3.2 France Castor Oil-Based Biopolymer Market (by Form), Volume and Value Data
4.2.4.3 Italy
4.2.4.3.1 Market
4.2.4.3.1.1 Buyer Attributes
4.2.4.3.1.2 Key Producers and Suppliers in Italy
4.2.4.3.1.3 Business Drivers
4.2.4.3.1.4 Business Challenges
4.2.4.3.2 Applications
4.2.4.3.2.1 Italy Castor Oil-Based Biopolymer Market (by End User), Volume and Value Data
4.2.4.3.3 Products
4.2.4.3.3.1 Italy Castor Oil-Based Biopolymer Market (by Polymer Type), Volume and Value Data
4.2.4.3.3.2 Italy Castor Oil-Based Biopolymer Market (by Form), Volume and Value Data
4.2.4.4 Spain
4.2.4.4.1 Market
4.2.4.4.1.1 Buyer Attributes
4.2.4.4.1.2 Key Producers and Suppliers in Spain
4.2.4.4.1.3 Business Drivers
4.2.4.4.1.4 Business Challenges
4.2.4.4.2 Applications
4.2.4.4.2.1 Spain Castor Oil-Based Biopolymer Market (by End User), Volume and Value Data
4.2.4.4.3 Products
4.2.4.4.3.1 Spain Castor Oil-Based Biopolymer Market (by Polymer Type), Volume and Value Data
4.2.4.4.3.2 Spain Castor Oil-Based Biopolymer Market (by Form), Volume and Value Data
4.2.4.5 Rest-of-Europe
4.2.4.5.1 Market
4.2.4.5.1.1 Buyer Attributes
4.2.4.5.1.2 Key Producers and Suppliers in Rest-of-Europe
4.2.4.5.1.3 Business Drivers
4.2.4.5.1.4 Business Challenges
4.2.4.5.2 Applications
4.2.4.5.2.1 Rest-of-Europe Castor Oil-Based Biopolymer Market (by End User), Volume and Value Data
4.2.4.5.3 Products
4.2.4.5.3.1 Rest-of-Europe Castor Oil-Based Biopolymer Market (by Polymer Type), Volume and Value Data
4.2.4.5.3.2 Rest-of-Europe Castor Oil-Based Biopolymer Market (by Form), Volume and Value Data
4.3 U.K.
4.3.1 Market
4.3.1.1 Buyer Attributes
4.3.1.2 Key Producers and Suppliers in the U.K.
4.3.1.3 Business Drivers
4.3.1.4 Business Challenges
4.3.2 Applications
4.3.2.1 U.K. Castor Oil-Based Biopolymer Market (by End User), Volume and Value Data
4.3.3 Products
4.3.3.1 U.K. Castor Oil-Based Biopolymer Market (by Polymer Type), Volume and Value Data
4.3.3.2 U.K. Castor Oil-Based Biopolymer Market (by Form), Volume and Value Data
4.4 China
4.4.1 Market
4.4.1.1 Buyer Attributes
4.4.1.2 Key Producers and Suppliers in China
4.4.1.3 Business Drivers
4.4.1.4 Business Challenges
4.4.2 Applications
4.4.2.1 China Castor Oil-Based Biopolymer Market (by End User), Volume and Value Data
4.4.3 Products
4.4.3.1 China Castor Oil-Based Biopolymer Market (by Polymer Type), Volume and Value Data
4.4.3.2 China Castor Oil-Based Biopolymer Market (by Form), Volume and Value Data
4.5 Asia-Pacific and Japan
4.5.1 Market
4.5.1.1 Key Producers and Suppliers in Asia-Pacific and Japan
4.5.1.2 Business Drivers
4.5.1.3 Business Challenges
4.5.2 Applications
4.5.2.1 Asia-Pacific and Japan Castor Oil-Based Biopolymer Market (by End User), Volume and Value Data
4.5.3 Products
4.5.3.1 Asia-Pacific and Japan Castor Oil-Based Biopolymer Market (by Polymer Type), Volume and Value Data
4.5.3.2 Asia-Pacific and Japan Castor Oil-Based Biopolymer Market (by Form), Volume and Value Data
4.5.4 Asia-Pacific and Japan (by Country)
4.5.4.1 Japan
4.5.4.1.1 Market
4.5.4.1.1.1 Buyer Attributes
4.5.4.1.1.2 Key Producers and Suppliers in Japan
4.5.4.1.1.3 Business Drivers
4.5.4.1.1.4 Business Challenges
4.5.4.1.2 Applications
4.5.4.1.2.1 Japan Castor Oil-Based Biopolymer Market (by End User), Volume and Value Data
4.5.4.1.3 Products
4.5.4.1.3.1 Japan Castor Oil-Based Biopolymer Market (by Polymer Type), Volume and Value Data
4.5.4.1.3.2 Japan Castor Oil-Based Biopolymer Market (by Form), Volume and Value Data
4.5.4.2 South Korea
4.5.4.2.1 Market
4.5.4.2.1.1 Buyer Attributes
4.5.4.2.1.2 Key Producers and Suppliers in South Korea
4.5.4.2.1.3 Business Drivers
4.5.4.2.1.4 Business Challenges
4.5.4.2.2 Applications
4.5.4.2.2.1 South Korea Castor Oil-Based Biopolymer Market (by End User), Volume and Value Data
4.5.4.2.3 Products
4.5.4.2.3.1 South Korea Castor Oil-Based Biopolymer Market (by Polymer Type), Volume and Value Data
4.5.4.2.3.2 South Korea Castor Oil-Based Biopolymer Market (by Form), Volume and Value Data
4.5.4.3 India
4.5.4.3.1 Market
4.5.4.3.1.1 Buyer Attributes
4.5.4.3.1.2 Key Producers and Suppliers in India
4.5.4.3.1.3 Business Drivers
4.5.4.3.1.4 Business Challenges
4.5.4.3.2 Applications
4.5.4.3.2.1 India Castor Oil-Based Biopolymer Market (by End User), Volume and Value Data
4.5.4.3.3 Products
4.5.4.3.3.1 India Castor Oil-Based Biopolymer Market (by Polymer Type), Volume and Value Data
4.5.4.3.3.2 India Castor Oil-Based Biopolymer Market (by Form), Volume and Value Data
4.5.4.4 Rest-of-Asia-Pacific
4.5.4.4.1 Market
4.5.4.4.1.1 Buyer Attributes
4.5.4.4.1.2 Key Producers and Suppliers in Rest-of-Asia-Pacific
4.5.4.4.1.3 Business Drivers
4.5.4.4.1.4 Business Challenges
4.5.4.4.2 Applications
4.5.4.4.2.1 Rest-of-Asia-Pacific Castor Oil-Based Biopolymer Market (by End User), Volume and Value Data
4.5.4.4.3 Products
4.5.4.4.3.1 Rest-of-Asia-Pacific Castor Oil-Based Biopolymer Market (by Polymer Type), Volume and Value Data
4.5.4.4.3.2 Rest-of-Asia-Pacific Castor Oil-Based Biopolymer Market (by Form), Volume and Value Data
4.6 Rest-of-the-World
4.6.1 Market
4.6.1.1 Key Producers and Suppliers in Rest-of-the-World
4.6.1.2 Business Drivers
4.6.1.3 Business Challenges
4.6.2 Applications
4.6.2.1 Rest-of-the-World Castor Oil-Based Biopolymer Market (by End User), Volume and Value Data
4.6.3 Products
4.6.3.1 Rest-of-the-World Castor Oil-Based Biopolymer Market (by Polymer Type), Volume and Value Data
4.6.3.2 Rest-of-the-World Castor Oil-Based Biopolymer Market (by Form), Volume and Value Data
4.6.4 Rest-of-the-World (by Region)
4.6.4.1 Middle East and Africa
4.6.4.1.1 Market
4.6.4.1.1.1 Buyer Attributes
4.6.4.1.1.2 Key Producers and Suppliers in the Middle East and Africa
4.6.4.1.1.3 Business Drivers
4.6.4.1.1.4 Business Challenges
4.6.4.1.2 Applications
4.6.4.1.2.1 Middle East and Africa Castor Oil-Based Biopolymer Market (by End User), Volume and Value Data
4.6.4.1.3 Products
4.6.4.1.3.1 Middle East and Africa Castor Oil-Based Biopolymer Market (by Polymer Type), Volume and Value Data
4.6.4.1.3.2 Middle East and Africa Castor Oil-Based Biopolymer Market (by Form), Volume and Value Data
4.6.4.2 South America
4.6.4.2.1 Market
4.6.4.2.1.1 Buyer Attributes
4.6.4.2.1.2 Key Producers and Suppliers in South America
4.6.4.2.1.3 Business Drivers
4.6.4.2.1.4 Business Challenges
4.6.4.2.2 Applications
4.6.4.2.2.1 South America Castor Oil-Based Biopolymer Market (by End User), Volume and Value Data
4.6.4.2.3 Products
4.6.4.2.3.1 South America Castor Oil-Based Biopolymer Market (by Polymer Type), Volume and Value Data
4.6.4.2.3.2 South America Castor Oil-Based Biopolymer Market (by Form), Volume and Value Data

5 Markets – Competitive Benchmarking & Company Profiles
5.1 Competitive Benchmarking (2021)
5.1.1 Competitive Position Matrix (2021)
5.1.2 Product Matrix for Key Companies, By Form
5.1.3 Market Share Analysis of Key Companies, 2021
5.2 Company Profiles
5.2.1 Arkema
5.2.1.1 Company Overview
5.2.1.1.1 Role of Arkema in the Castor Oil-Based Biopolymer Market
5.2.1.1.2 Product Portfolio
5.2.1.1.3 Production Site
5.2.1.2 Business Strategies
5.2.1.2.1 Market Developments
5.2.1.3 R&D Analysis
5.2.1.4 Analyst View
5.2.2 Evonik Industries AG
5.2.2.1 Company Overview
5.2.2.1.1 Role of Evonik Industries AG in the Castor Oil-Based Biopolymer Market
5.2.2.1.2 Product Portfolio
5.2.2.1.3 Production Site
5.2.2.2 Business Strategies
5.2.2.2.1 Market Developments
5.2.2.3 R&D Analysis
5.2.2.4 Analyst View
5.2.3 BASF SE
5.2.3.1 Company Overview
5.2.3.1.1 Role of BASF SE in the Castor Oil-Based Biopolymer Market
5.2.3.1.2 Product Portfolio
5.2.3.1.3 Production Sites
5.2.3.2 R&D Analysis
5.2.3.3 Analyst View
5.2.4 EMS-Chemie Holding AG
5.2.4.1 Company Overview
5.2.4.1.1 Role of EMS-Chemie Holding AG in the Castor Oil-Based Biopolymer Market
5.2.4.1.2 Product Portfolio
5.2.4.1.3 Production Site
5.2.4.2 R&D Analysis
5.2.4.3 Analyst View
5.2.5 Solvay S.A.
5.2.5.1 Company Overview
5.2.5.1.1 Role of Solvay S.A. in the Castor Oil-Based Biopolymer Market
5.2.5.1.2 Product Portfolio
5.2.5.1.3 Production Site
5.2.5.2 R&D Analysis
5.2.5.3 Analyst View
5.2.6 Toray Industries, Inc.
5.2.6.1 Company Overview
5.2.6.1.1 Role of Toray Industries, Inc. in the Castor Oil-Based Biopolymer Market
5.2.6.1.2 Product Portfolio
5.2.6.1.3 Production Site
5.2.6.2 Business Strategies
5.2.6.2.1 Market Developments
5.2.6.3 R&D Analysis
5.2.6.4 Analyst View
5.2.7 UNITIKA LTD.
5.2.7.1 Company Overview
5.2.7.1.1 Role of UNITIKA LTD. in the Castor Oil-Based Biopolymer Market
5.2.7.1.2 Product Portfolio
5.2.7.1.3 Production Site
5.2.7.2 R&D Analysis
5.2.7.3 Analyst View
5.2.8 RadiciGroup
5.2.8.1 Company Overview
5.2.8.1.1 Role of RadiciGroup in the Castor Oil-Based Biopolymer Market
5.2.8.1.2 Product Portfolio
5.2.8.1.3 Production Site
5.2.8.2 Analyst View
5.2.9 Fulgar SpA
5.2.9.1 Company Overview
5.2.9.1.1 Role of Fulgar SpA in the Castor Oil-Based Biopolymer Market
5.2.9.1.2 Product Portfolio
5.2.9.1.3 Production Site
5.2.9.2 Analyst View
5.2.10 DSM
5.2.10.1 Company Overview
5.2.10.1.1 Role of DSM in the Castor Oil-Based Biopolymer Market
5.2.10.1.2 Product Portfolio
5.2.10.1.3 Production Site
5.2.10.2 R&D Analysis
5.2.10.3 Analyst View
5.2.11 DuPont de Nemours, Inc.
5.2.11.1 Company Overview
5.2.11.1.1 Role of DuPont de Nemours, Inc. in the Castor Oil-Based Biopolymer Market
5.2.11.1.2 Product Portfolio
5.2.11.1.3 Production Site
5.2.11.2 Business Strategies
5.2.11.2.1 Market Developments
5.2.11.3 R&D Analysis
5.2.11.4 Analyst View
5.2.12 Mitsui Chemicals Inc.
5.2.12.1 Company Overview
5.2.12.1.1 Role of Mitsui Chemicals Inc. in the Castor Oil-Based Biopolymer Market
5.2.12.1.2 Product Portfolio
5.2.12.1.3 Production Site
5.2.12.2 Business Strategies
5.2.12.2.1 Market Developments
5.2.12.3 R&D Analysis
5.2.12.4 Analyst View
5.2.13 Nexis Fibers
5.2.13.1 Company Overview
5.2.13.1.1 Role of Nexis Fibers in the Castor Oil-Based Biopolymer Market
5.2.13.1.2 Product Portfolio
5.2.13.1.3 Production Site
5.2.13.2 Business strategies
5.2.13.2.1 Product development
5.2.13.3 Analyst View
5.2.14 VAUDE Sport GmbH & Co. KG
5.2.14.1 Company Overview
5.2.14.1.1 Role of VAUDE Sport GmbH & Co. KG in the Castor Oil-Based Biopolymer Market
5.2.14.1.2 Product Portfolio
5.2.14.2 Analyst View
5.2.15 EOS GmbH
5.2.15.1 Company Overview
5.2.15.1.1 Role of EOS GmbH in the Castor Oil-Based Biopolymer Market
5.2.15.1.2 Product Portfolio
5.2.15.1.3 Analyst View
5.2.16 AWAKE CONCEPT
5.2.16.1 Company Overview
5.2.16.1.1 Role of AWAKE CONCEPT in the Castor Oil-Based Biopolymer Market
5.2.16.1.2 Product Portfolio
5.2.16.1.3 Production Site
5.2.16.2 Business Strategies
5.2.16.2.1 Product development
5.2.16.3 Analyst View
5.2.17 NEUBAU EYEWEAR gmbh
5.2.17.1 Company Overview
5.2.17.1.1 Role of NEUBAU EYEWEAR gmbh in the Castor Oil-Based Biopolymer Market
5.2.17.1.2 Product Portfolio
5.2.17.1.3 Production Site
5.2.17.2 Business Strategies
5.2.17.2.1 Market Developments
5.2.17.3 Analyst View
5.2.18 Lanxess AG
5.2.18.1 Company Overview
5.2.18.1.1 Role of Lanxess AG in the Castor Oil-Based Biopolymer Market
5.2.18.1.2 Product Portfolio
5.2.18.1.3 Production Site
5.2.18.2 Business Strategies
5.2.18.2.1 Product Developments
5.2.18.3 R&D Analysis
5.2.18.4 Analyst View
5.2.19 BIO-FED
5.2.19.1 Company Overview
5.2.19.1.1 Role of BIO-FED in the Castor Oil-Based Biopolymer Market
5.2.19.1.2 Product Portfolio
5.2.19.1.3 Production Site
5.2.19.2 Analyst View
5.2.20 Asahi Kasei Corporation
5.2.20.1 Company Overview
5.2.20.1.1 Role of Asahi Kasei Corporation in the Castor Oil-Based Biopolymer Market
5.2.20.1.2 Product Portfolio
5.2.20.1.3 Production Site
5.2.20.2 Corporate Strategies
5.2.20.2.1 Partnerships, Collaborations, and Joint Ventures
5.2.20.3 R&D Analysis
5.2.20.4 Analyst View

6 Research Methodology

List of Figures
Figure 1: Global Castor Oil-Based Biopolymer Market, $Million, 2021, 2022, and 2031
Figure 2: Global Castor Oil-Based Biopolymer Market (by End User), $Million, 2021 and 2031
Figure 3: Global Castor Oil-Based Biopolymer Market (by Polymer Type), $Million, 2021 and 2031
Figure 4: Global Castor Oil-Based Biopolymer Market (by Form), $Million, 2021 and 2031
Figure 5: Global Castor Oil-Based Biopolymer Market (by Region), $Million, 2021 and 2031
Figure 6: Global Castor Oil-Based Biopolymer Market Coverage
Figure 7: Supply Chain Analysis of the Castor Oil-Based Biopolymer Market
Figure 8: Global Automotive Production, Units (2019-2021)
Figure 9: World Passenger Car Production, Million Units, Q1 to Q3 (FY2022) and Q1 to Q3 (FY2021)
Figure 10: Global Polyamide Production, Million Tons, 2017-2021
Figure 11: Comparative Densities of Engineering Polymers and Aluminum (g/cm2)
Figure 12: Production of Castor in India, Lakh Tons, 2017-2021
Figure 13: 3D Printing Market, $Billion, 2021-2026
Figure 14: Castor Oil-Based Biopolymer Market (by End User)
Figure 15: Castor Oil-Based Biopolymer Market (by Polymer Type)
Figure 16: Castor Oil-Based Biopolymer Market (by Form)
Figure 17: Total Year-Wise Patents Filed for Castor Oil-Based Biopolymer Market, January 2019-December 2022
Figure 18: Patent Analysis (by Organization), January 2019-December 2022
Figure 19: Research Methodology
Figure 20: Top-Down and Bottom-Up Approach
Figure 21: Castor Oil-Based Biopolymer Market Influencing Factors
Figure 22: Assumptions and Limitations

List of Tables
Table 1: Key Bio-Based Polyamide Fibers and Yarns Manufacturers
Table 2: Key Product Developments
Table 3: Key Market Developments (2018-2021)
Table 4: Castor Oil-Based Biopolymer Market (by End User), Kilo Tons, 2021-2031
Table 5: Castor Oil-Based Biopolymer Market (by End User), $Million, 2021-2031
Table 6: Castor Oil-Based Biopolymer Market (by Polymer Type), Kilo Tons, 2021-2031
Table 7: Castor Oil-Based Biopolymer Market (by Polymer Type), $Million, 2021-2031
Table 8: Castor Oil-Based Biopolymer Market (by Form), Kilo Tons, 2021-2031

Table 9: Castor Oil-Based Biopolymer Market (by Form), $Million, 2021-2031
Table 10: Castor Oil-Based Biopolymer Market: Global Level – Average Pricing Analysis, ($/kg), 2021-2031
Table 11: Castor Oil-Based Biopolymer Market: Average Pricing Analysis, (by Polymer Type), ($/kg), 2021-2031
Table 12: North America Castor Oil-Based Biopolymer Market (by End User), Kilo Tons, 2021-2031
Table 13: North America Castor Oil-Based Biopolymer Market (by End User), $Million, 2021-2031
Table 14: North America Castor Oil-Based Biopolymer Market (by Polymer Type), Kilo Tons, 2021-2031
Table 15: North America Castor Oil-Based Biopolymer Market (by Polymer Type), $Million, 2021-2031
Table 16: North America Castor Oil-Based Biopolymer Market (by Form), Kilo Tons, 2021-2031
Table 17: North America Castor Oil-Based Biopolymer Market (by Form), $Million, 2021-2031
Table 18: U.S. Castor Oil-Based Biopolymer Market (by End User), Kilo Tons, 2021-2031
Table 19: U.S. Castor Oil-Based Biopolymer Market (by End User), $Million, 2021-2031
Table 20: U.S. Castor Oil-Based Biopolymer Market (by Polymer Type), Kilo Tons, 2021-2031
Table 21: U.S. Castor Oil-Based Biopolymer Market (by Polymer Type), $Million, 2021-2031
Table 22: U.S. Castor Oil-Based Biopolymer Market (by Form), Kilo Tons, 2021-2031
Table 23: U.S. Castor Oil-Based Biopolymer Market (by Form), $Million, 2021-2031
Table 24: Canada Castor Oil-Based Biopolymer Market (by End User), Kilo Tons, 2021-2031
Table 25: Canada Castor Oil-Based Biopolymer Market (by End User), $Million, 2021-2031
Table 26: Canada Castor Oil-Based Biopolymer Market (by Polymer Type), Kilo Tons, 2021-2031
Table 27: Canada Castor Oil-Based Biopolymer Market (by Polymer Type), $Million, 2021-2031
Table 28: Canada Castor Oil-Based Biopolymer Market (by Form), Kilo Tons, 2021-2031
Table 29: Canada Castor Oil-Based Biopolymer Market (by Form), $Million, 2021-2031
Table 30: Mexico Castor Oil-Based Biopolymer Market (by End User), Kilo Tons, 2021-2031
Table 31: Mexico Castor Oil-Based Biopolymer Market (by End User), $Million, 2021-2031
Table 32: Mexico Castor Oil-Based Biopolymer Market (by Polymer Type), Kilo Tons, 2021-2031
Table 33: Mexico Castor Oil-Based Biopolymer Market (by Polymer Type), $Million, 2021-2031
Table 34: Mexico Castor Oil-Based Biopolymer Market (by Form), Kilo Tons, 2021-2031
Table 35: Mexico Castor Oil-Based Biopolymer Market (by Form), $Million, 2021-2031
Table 36: Europe Castor Oil-Based Biopolymer Market (by End User), Kilo Tons, 2021-2031
Table 37: Europe Castor Oil-Based Biopolymer Market (by End User), $Million, 2021-2031
Table 38: Europe Castor Oil-Based Biopolymer Market (by Polymer Type), Kilo Tons, 2021-2031
Table 39: Europe Castor Oil-Based Biopolymer Market (by Polymer Type), $Million, 2021-2031
Table 40: Europe Castor Oil-Based Biopolymer Market (by Form), Kilo Tons, 2021-2031
Table 41: Europe Castor Oil-Based Biopolymer Market (by For”

The post Castor Oil-Based Biopolymer Market – A Global and Regional Analysis: Focus on End User, Polymer Type, Form, and Region – Analysis and Forecast, 2022-2031 first appeared on CRI Report.

According to CRI’s report, the global sequencing reagents market is assessed to observe a growth trend at a CAGR of 12.83% based on revenue through the considered period 2021-2028.

The ongoing research in genomics due to the rise in chronic diseases, along with the advancement in genomics following the launch of new technologies, are driving the studied market on a growth path. Additionally, investments by manufacturers and governments in genomics are opening new avenues for the market globally.

Conversely, social and ethical issues relating to data privacy and the lack of professionals in developing regions impede the overall growth of the sequencing reagents market.

REGIONAL OUTLOOK

The global sequencing reagents market comprises the Asia-Pacific, North America, Latin America, Europe, and the Middle East and Africa regions.
Geographically, the Asia-Pacific is estimated to emerge as the fastest evolving region in the sequencing reagents market over the reviewed period. The region’s robust growth can be attributed to the surging investments by government bodies across the major countries.

Moreover, the increase in research and development of genomics is another factor contributing to the studied market’s growth. For instance, the Indian government has introduced initiatives for startups in the biotechnology sector, which will ultimately foster the growth of the sequencing reagents market.

COMPETITIVE OUTLOOK

The key companies thriving in the sequencing reagents market are F Hoffmann La Roche, Illumina Inc, Perkinelmer Inc, Qiagen NV, Bio Rad Laboratories Inc, Trilink Biotechnologies Inc, Asuragen Inc, Merck KGAA, Agilent Technologies Inc, BGI Genomics, Thermo Fisher Scientific Inc, Fluidigm Corporation, Pacific Biosciences of California Inc, Takara Bio Inc, and LGC Biosearch Technologies.

Thermo Fisher Scientific Inc is a leading company operating under various business segments, such as laboratory products & services, analytical instruments, specialty diagnostics, and life sciences solutions. It develops and delivers its products to research institutes, government agencies, universities, hospitals, and pharmaceutical companies, among others. Founded in 2006, Thermo Fisher has a presence across more than 50 nations. It is headquartered in Massachusetts, the United States.

TABLE OF CONTENTS

1. GLOBAL SEQUENCING REAGENTS MARKET – SUMMARY

2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON SEQUENCING REAGENTS MARKET
2.2. KEY INSIGHTS
2.3. PORTER’S FIVE FORCES MODEL
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. COMPETITIVE RIVALRY
2.4. SUPPLY CHAIN OUTLOOK
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. KEY STRATEGIC DEVELOPMENTS
2.7.1. CONTRACTS AND PARTNERSHIPS
2.7.2. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
2.7.3. ACQUISITIONS & MERGERS
2.7.4. NEW PRODUCT LAUNCHES & DEVELOPMENTS
2.8. MARKET DRIVERS
2.8.1. ONGOING RESEARCH IN GENOMICS DUE TO THE PREVALENCE OF CHRONIC DISEASES
2.8.2. ADVANCES IN GENOMICS AFTER THE LAUNCH OF NEW TECHNOLOGIES
2.9. MARKET CHALLENGES
2.9.1. SOCIAL AND ETHICAL ISSUES RELATED TO DATA PRIVACY
2.9.2. LACK OF PROFESSIONALS IN DEVELOPING COUNTRIES
2.10. MARKET OPPORTUNITIES
2.10.1. FUNDING BY MANUFACTURERS AND GOVERNMENT IN GENOMICS
2.10.2. GROWING DEMAND FOR THIRD-GENERATION SEQUENCING

3. GLOBAL SEQUENCING REAGENTS MARKET – BY APPLICATION
3.1. ONCOLOGY
3.2. CLINICAL INVESTIGATION
3.3. AGRI GENOMICS AND FORENSICS
3.4. REPRODUCTIVE HEALTH
3.5. OTHER APPLICATIONS

4. GLOBAL SEQUENCING REAGENTS MARKET – BY REAGENT TYPE
4.1. SEQUENCING KITS
4.2. CONTROL KITS
4.3. LIBRARY KITS
4.4. TEMPLATE KITS
4.5. OTHER REAGENT TYPES

5. GLOBAL SEQUENCING REAGENTS MARKET – BY TECHNOLOGY
5.1. NEXT-GENERATION SEQUENCING
5.2. SANGER SEQUENCING
5.3. THIRD-GENERATION SEQUENCING

6. GLOBAL SEQUENCING REAGENTS MARKET – BY INDUSTRY VERTICALS
6.1. RESEARCH INSTITUTES
6.2. HOSPITALS AND CLINICS
6.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
6.4. OTHER INDUSTRY VERTICALS

7. GLOBAL SEQUENCING REAGENTS MARKET – REGIONAL OUTLOOK
7.1. NORTH AMERICA
7.1.1. MARKET BY APPLICATION
7.1.2. MARKET BY REAGENT TYPE
7.1.3. MARKET BY TECHNOLOGY
7.1.4. MARKET BY INDUSTRY VERTICALS
7.1.5. COUNTRY ANALYSIS
7.1.5.1. UNITED STATES
7.1.5.2. CANADA
7.2. EUROPE
7.2.1. MARKET BY APPLICATION
7.2.2. MARKET BY REAGENT TYPE
7.2.3. MARKET BY TECHNOLOGY
7.2.4. MARKET BY INDUSTRY VERTICALS
7.2.5. COUNTRY ANALYSIS
7.2.5.1. GERMANY
7.2.5.2. FRANCE
7.2.5.3. UNITED KINGDOM
7.2.5.4. ITALY
7.2.5.5. RUSSIA
7.2.5.6. SPAIN
7.2.5.7. REST OF EUROPE
7.3. ASIA-PACIFIC
7.3.1. MARKET BY APPLICATION
7.3.2. MARKET BY REAGENT TYPE
7.3.3. MARKET BY TECHNOLOGY
7.3.4. MARKET BY INDUSTRY VERTICALS
7.3.5. COUNTRY ANALYSIS
7.3.5.1. CHINA
7.3.5.2. JAPAN
7.3.5.3. INDIA
7.3.5.4. AUSTRALIA & NEW ZEALAND
7.3.5.5. SOUTH KOREA
7.3.5.6. ASEAN COUNTRIES
7.3.5.7. REST OF ASIA-PACIFIC
7.4. LATIN AMERICA
7.4.1. MARKET BY APPLICATION
7.4.2. MARKET BY REAGENT TYPE
7.4.3. MARKET BY TECHNOLOGY
7.4.4. MARKET BY INDUSTRY VERTICALS
7.4.5. COUNTRY ANALYSIS
7.4.5.1. BRAZIL
7.4.5.2. MEXICO
7.4.5.3. REST OF LATIN AMERICA
7.5. MIDDLE EAST AND AFRICA
7.5.1. MARKET BY APPLICATION
7.5.2. MARKET BY REAGENT TYPE
7.5.3. MARKET BY TECHNOLOGY
7.5.4. MARKET BY INDUSTRY VERTICALS
7.5.5. COUNTRY ANALYSIS
7.5.5.1. SAUDI ARABIA
7.5.5.2. UNITED ARAB EMIRATES
7.5.5.3. TURKEY
7.5.5.4. SOUTH AFRICA
7.5.5.5. REST OF MIDDLE EAST & AFRICA

8. COMPANY PROFILE
8.1. AGILENT TECHNOLOGIES INC
8.2. ASURAGEN INC
8.3. BGI GENOMICS
8.4. BIO RAD LABORATORIES INC
8.5. F HOFFMANN LA ROCHE
8.6. FLUIDIGM CORPORATION
8.7. ILLUMINA INC
8.8. LGC BIOSEARCH TECHNOLOGIES
8.9. MERCK KGAA
8.10. PACIFIC BIOSCIENCES OF CALIFORNIA INC
8.11. PERKINELMER INC
8.12. QIAGEN NV
8.13. TAKARA BIO INC
8.14. THERMO FISHER SCIENTIFIC INC
8.15. TRILINK BIOTECHNOLOGIES INC

9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.1.1. OBJECTIVES OF STUDY
9.1.2. SCOPE OF STUDY
9.2. SOURCES OF DATA
9.2.1. PRIMARY DATA SOURCES
9.2.2. SECONDARY DATA SOURCES
9.3. RESEARCH METHODOLOGY
9.3.1. EVALUATION OF PROPOSED MARKET
9.3.2. IDENTIFICATION OF DATA SOURCES
9.3.3. ASSESSMENT OF MARKET DETERMINANTS
9.3.4. DATA COLLECTION
9.3.5. DATA VALIDATION & ANALYSIS

LIST OF TABLES

TABLE 1: GLOBAL SEQUENCING REAGENTS MARKET, REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF CONTRACTS AND PARTNERSHIPS
TABLE 4: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
TABLE 5: LIST OF ACQUISITIONS & MERGERS
TABLE 6: LIST OF NEW PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 7: GLOBAL SEQUENCING REAGENTS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 8: GLOBAL SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: GLOBAL SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 10: GLOBAL SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 11: GLOBAL SEQUENCING REAGENTS MARKET, REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 13: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 14: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 15: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 16: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 17: EUROPE SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 18: EUROPE SEQUENCING REAGENTS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 19: EUROPE SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 20: EUROPE SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 21: EUROPE SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 22: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 23: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 24: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 25: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 26: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 27: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 28: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 29: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 30: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 31: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 32: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 33: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 34: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 35: MIDDLE EAST AND AFRICA SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1: GLOBAL SEQUENCING REAGENTS MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 2: GLOBAL SEQUENCING REAGENTS MARKET, BY ONCOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 3: GLOBAL SEQUENCING REAGENTS MARKET, BY CLINICAL INVESTIGATION, 2021-2028 (IN $ MILLION)
FIGURE 4: GLOBAL SEQUENCING REAGENTS MARKET, BY AGRI GENOMICS AND FORENSICS, 2021-2028 (IN $ MILLION)
FIGURE 5: GLOBAL SEQUENCING REAGENTS MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)
FIGURE 6: GLOBAL SEQUENCING REAGENTS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 7: GLOBAL SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2020 & 2028 (IN %)
FIGURE 8: GLOBAL SEQUENCING REAGENTS MARKET, BY SEQUENCING KITS, 2021-2028 (IN $ MILLION)
FIGURE 9: GLOBAL SEQUENCING REAGENTS MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)
FIGURE 10: GLOBAL SEQUENCING REAGENTS MARKET, BY LIBRARY KITS, 2021-2028 (IN $ MILLION)
FIGURE 11: GLOBAL SEQUENCING REAGENTS MARKET, BY TEMPLATE KITS, 2021-2028 (IN $ MILLION)
FIGURE 12: GLOBAL SEQUENCING REAGENTS MARKET, BY OTHER REAGENT TYPES, 2021-2028 (IN $ MILLION)
FIGURE 13: GLOBAL SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)
FIGURE 14: GLOBAL SEQUENCING REAGENTS MARKET, BY NEXT-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 15: GLOBAL SEQUENCING REAGENTS MARKET, BY SANGER SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 16: GLOBAL SEQUENCING REAGENTS MARKET, BY THIRD-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 17: GLOBAL SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE 18: GLOBAL SEQUENCING REAGENTS MARKET, BY RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 19: GLOBAL SEQUENCING REAGENTS MARKET, BY HOSPITALS AND CLINICS, 2021-2028 (IN $ MILLION)
FIGURE 20: GLOBAL SEQUENCING REAGENTS MARKET, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 21: GLOBAL SEQUENCING REAGENTS MARKET, BY OTHER INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
FIGURE 22: UNITED STATES SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: CANADA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: GERMANY SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 25: FRANCE SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: UNITED KINGDOM SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: ITALY SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 28: RUSSIA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 29: SPAIN SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 30: REST OF EUROPE SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 31: CHINA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 32: JAPAN SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 33: INDIA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 34: AUSTRALIA & NEW ZEALAND SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 35: SOUTH KOREA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 36: ASEAN COUNTRIES SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 37: REST OF ASIA-PACIFIC SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 38: BRAZIL SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 39: MEXICO SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 40: REST OF LATIN AMERICA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 41: SAUDI ARABIA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 42: UNITED ARAB EMIRATES SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 43: TURKEY SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 44: SOUTH AFRICA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 45: REST OF MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)

The post GLOBAL SEQUENCING REAGENTS MARKET 2021-2028 first appeared on CRI Report.

Market Segmentation

• Product Type – Hardware and Software
• Application – Implantology, Endodontics, Oral and Maxillofacial Surgery, Orthodontics and Others
• End User – Hospitals, Dental Centers and Clinics, and Academic and Research Institutes

Regional Segmentation

• North America – U.S. and Canada
• Europe – Germany, U.K., France, Italy, Spain, and Rest-of-Europe
• Asia-Pacific – Japan, China, South Korea, India, Australia and New Zealand, and Rest-of-Asia-Pacific
• Rest-of-the-World – Latin America and Middle East and Africa

Market Growth Drivers

• Increasing Incidence of Oral Diseases and Traumatic Injuries
• Technological Advancement Through New Product Development and Collaborative Activities
• Surge in Dental Tourism

Market Challenges

• High Cost of Dental Equipment and Software
• Exposure to Ionizing Radiations

Market Opportunities

• High Growth Opportunity in the Emerging Economies
• Increasing Demand for Cosmetic Dentistry

Key Companies Profiled

3Shape A/S, Acteon Group, Asahi Roentgen Ind. Co., Ltd., Carestream Dental, LLC, Cefla Medical Equipment, Dentsply Sirona, Inc., DÜRR DENTAL SE, Envista Holdings Corporation, J. MORITA Corporation, Medit Corporation, Midmark Corporation, Planmeca Group, Straumann Group, Takara Belmont Corporation, VATECH Co., Ltd.

How This Report Can Add Value

The report will be most beneficial for manufacturers of dental radiography system.

Assuming that the reader is a manufacturer of dental radiography, the report will assist them in the following ways:

• Understand their position compared to other key players in the market
• Stay updated with novel technology integration, features, and the latest developments in the market
• Understand the impact of COVID-19 on dental radiography and the entry barriers for new companies
• Gain insights into end-user perception concerning the dental radiography market
• Identify some key players in the market and understand their valuable contribution

Key Questions Answered in the Report

• How has COVID-19 impacted the growth of the global dental radiography market?
• What are the key regulations governing the dental radiography market in key regions?
• What technological developments are projected to have the maximum influence on the global dental radiography market?
• Who are the leading players holding significant dominance in the global dental radiography market?
• What are some of the growth opportunities which market players can capitalize on?
• What are the drivers and restraints for the global dental radiography market?
• Which region has the highest growth rate in the dental radiography market?
• Which are the fastest growing countries in terms of the global dental radiography market?
• What are the key strategies being adopted by market players in the global dental radiography market?
• Which are the emerging companies in the global dental radiography market?

Global Dental Radiography Market Industry Overview

The global dental radiography market is projected to witness significant growth during the forecast period 2022-2031. The high prevalence and growing incidences of oral cancer, oral disorders and the technological advancements in dental radiography systems are the key propellers for the growth of the market. The development of advancements such as integration of software with the dental imaging systems, surge in dental tourism and increased awareness regarding dental care and oral hygiene are leading to the evolving of dental radiography continuously. In terms of regional markets potential, Europe and Asia-Pacific are projected to grow with considerable CAGR during the forecast period 2022-2031. The rising prevalence of oral disorders and oral cancer, rising need for cosmetic dentistry, growing technology adoption, and improving healthcare infrastructure are the macro factors that will advance the regions’ market growth.

The market for dental radiography devices is rapidly growing, with an increasing number of dental procedures requiring modalities. Oral cancer and oral disorders have emerged as serious public health concerns and rising awareness for oral health is driving the market forward. Various branches of dentistry such as implantology, endodontics, oral and maxillofacial surgery and orthodontics require radiography techniques as a basic diagnostic tool.

The global dental radiography market report highlights that the market was valued at $2,328.5 million in 2021 and is expected to reach $3,914.8 million by the end of 2031. The market is expected to grow at a CAGR of 5.17% during the forecast period 2022-2031.

Global Dental Radiography Market Drivers

The high prevalence and growing incidences of oral diseases are one of the major factors augmenting the global dental radiography market. Furthermore, dental radiography imaging systems are witnessing a better field of view in recent years. Extended fields of view are essential for panoramic radiographic imaging to analyze the anatomy of teeth, structural changes in mandible or maxilla, and surrounding soft tissues. The newly launched products in the global dental radiography market encompass necessary features that are required by dentists to carry out basic clinical functions as well as advanced surgical applications. As a result, the growth of oral diagnosis propels the global market for dental radiography.

Global Dental Radiography Market Restraints

The factors restraining the growth of the global dental radiography market include the risks associated with radiation exposure and delay in regulatory approvals. Exposure to ionizing radiations hinders the market’s growth. Moreover, another factor restraining the growth of the global dental radiography market is the high cost associated with dental procedures and equipment.

Global Dental Radiography Market Opportunities

High growth opportunities in emerging economies and the emergence of local companies in Asia-Pacific and the Middle East and Africa hold immense potential for the global dental radiography market growth. In an era of software and digitalization, increased demand for cosmetic dentistry aids in rising the global market for dental radiography.

Impact of COVID-19 on the Global Dental Radiography Market

The COVID-19 pandemic had a debilitating impact on the global healthcare ecosystem. Hospitals and clinics faced several challenges such as lack of resources, high patient influx, and risk of infection among care providers. The dental radiography market was negatively impacted due to the pandemic due to stoppage and postponing of elective procedures, including dental procedures. The market is projected to witness considerable growth during the forecast period 2022-2031. The increasing innovations and product designs in the global market and the growing use in emerging economies are the driving factors for the growth of the market.

Market Segmentation

Global Dental Radiography Market (by Product Type)

The global dental radiography market, based on product type, has been segmented into hardware and software. Hardware is further analyzed based on by modality (including X-Ray systems, CBCT systems and hybrid systems and others) and by imaging type (including extraoral imaging and intraoral imaging). Intraoral imaging is further segmented into sensors, PSP systems and others.

Global Dental Radiography Market (by Application)

The global dental radiography market, based on application, has been segmented into implantology, endodontics, oral and maxillofacial surgery, orthodontics and others.

Global Dental Radiography Market (by End User)

The global dental radiography market, based on end user, has been segmented into hospitals, dental centers and clinics, and academic and research institutes.

Dental center and clinics are the major end users for the global dental radiography market. The high volume of the end user makes them the primary diagnosis site for oral diseases and oral cancers in emerging economies.

Global Dental Radiography Market (by Region)

The different regions covered under the global dental radiography market include North America, Europe, Asia-Pacific and Rest-of-the-World.

North America is expected to be the most lucrative region for the global dental radiography market due to advanced healthcare infrastructure and a high focus on research and development activities. The Asia-Pacific dental radiography market is one of the lucrative markets with immense potential for expansion by key players of the global dental radiography market. The Asia-Pacific dental radiography market is expected to grow at the fastest rate during the forecast period. This can be attributed to the increasing prevalence and incidence of oral disorders and oral cancer, which is driving the increase in the volume of dental procedures requiring dental radiography.

Key Market Players and Competition Synopsis

Some key players operating in the market include Carestream Dental LLC, Midmark Corporation, Acteon Group, Dentsply Sirona, Inc., Envista Holdings Corporation, J. MORITA Corporation, Planmeca Group, Takara Belmont Corporation, Straumann Group, 3Shape A/S are DÜRR DENTAL SE, are few among others.

Some strategies covered in this segment are funding activities, mergers and acquisitions (M&As), partnerships, alliances, business expansion, regulatory and legal activities, and new offerings.

The post Dental Radiography Market – A Global and Regional Analysis: Focus on Product Type, Application, End User, and Region-Wise Analysis – Analysis and Forecast, 2022-2031 first appeared on CRI Report.

Market Segmentation

• Product Type – Continuous Positive Airway Pressure Device (CPAP), Automatic Positive Airway Pressure Device (APAP), Bi-Level Positive Airway Pressure Device (BiPAP)
• Indication – Sleep Apnea, Chronic Obstructive Pulmonary Disease (COPD), Others
• End User – Sleep Laboratories, Home Care, Others (Hospitals and Clinics, Elderly Care Homes, Nursing Homes, etc.)

Regional Segmentation

• North America – U.S. and Canada
• Europe – Germany, U.K., France, Italy, Spain, Nordic Countries, and Rest-of-Europe
• Asia-Pacific – Japan, China, India, Australia and New Zealand, South Korea, and the Rest-of-Asia-Pacific
• Latin America – Brazil, Mexico, Argentina, Colombia, and the Rest-of-Latin America
• Middle East and Africa – K.S.A., U.A.E., South Africa, and the Rest-of-Middle East and Africa

Market Growth Drivers

• Rising Number of Startups Driving Innovation
• Increasing Prevalence of Obstructive Sleep Apnea
• Growing Prevalence of Respiratory Diseases among the Geriatric Population
• Growing Prevalence of Chronic Respiratory Diseases across the Globe

Market Challenges

• High Upfront Cost of the Devices
• Side-Effects Associated with Long-Term Usage

Market Opportunities

• Development of Smart PAP Devices
• Deployment of 3D Scanning to Offer Customized PAP Masks
• Development of Accessory-Free PAP Devices

Key Companies Profiled

3B Medical, Inc, Apex Medical Corporation, BMC Medical Co. Ltd., Breas Medical AB, Compumedics Limited, Drive DeVilbiss Healthcare, Elmaslar Group, Fisher & Paykel Healthcare Corporation Limited, Hebei Topson Medical Technology Co., Ltd.,

Kare Medical and Analytical Devices Ltd. Co., Koninklijke Philips N.V., Löwenstein Medical Technology GmbH + Co. KG., Narang Medical Limited, ResMed Inc., Somnetics International, Inc.

How This Report Can Add Value

Assuming that the reader is a manufacturer of positive airway pressure devices, they will be able to do the following:

• Understand their position as compared to some of the key players in the market
• Get information on parameters such as device adoption rate, therapy compliance rate, and discontinuation rate
• Assess the disease epidemiology in each region
• Familiarize themselves with the necessary information related to changing market dynamics
• Stay updated with the latest trends in the market with respect to connected devices
• Understand the impact of COVID-19 on the market
• Identify some of the key players in the market and understand their value contribution

Key Questions Answered in the Global Positive Airway Pressure Devices Market Report:

• How has COVID-19 impacted the adoption of PAP devices in the market?
• What are the key regulations which influence the adoption of PAP devices in the market?
• What are some of the key companies in the global and regional PAP market?
• What are some of the key factors influencing the growth in adopting PAP devices across the globe?
• What are some of the growth opportunities which market players can capitalize on?
• What is the PAP device adoption rate for patients diagnosed with sleep apnea?
• What are the compliance and discontinuation rates for PAP therapy across regions?
• What are the fastest-growing countries in terms of PAP devices adoption?
• Which are the key diseases driving the adoption of PAP devices across the world?
• What are the key strategies being adopted by market players in the global positive airway pressure devices market?
• Who are the most common end-users of PAP devices, and how are the end-use segment expected to grow in the future?

Positive Airway Pressure Devices Market Industry Overview

A positive airway pressure delivery system is a prescription non-invasive ventilatory device that delivers expiratory positive airway pressure for patients suffering from obstructive sleep apnea. The system also provides positive airway pressure during incipient apnea.

The system may include a dedicated flow generator and a patient interface.

Sleep apnea is a sleep-related breathing disorder that involves a decrease or complete halt in airflow despite an ongoing effort to breathe. It occurs when the muscles relax during sleep, causing the soft tissue at the back of the throat to collapse and block the upper airway.

Obstructive sleep apnea is also one of the independent risk factors for stroke, cardiovascular diseases, and systemic hypertension, among other clinical consequences. Globally, sleep apnea impacts more than 936 million individuals worldwide.

The American Academy of Sleep Medicine (AASM) recommends that continuous positive airway pressure (CPAP) devices be considered first-line treatment for moderate and severe OSA.

Despite the recommendations, CPAP devices and PAP devices in general frequently encounter challenges in terms of adherence. There are a number of factors that contribute to the low adherence rates for PAP devices.

These factors primarily include claustrophobia, discomfort, and high cost. Several studies have been conducted to identify the reason behind low adherence rates despite several changes in the device and mask dynamics.

The global positive airway pressure devices market report highlights that the market was valued at $3,411.5 million in 2020 and is expected to reach $6,218.5 million by the end of 2030. The market is expected to grow at a CAGR of 6.03% during the forecast period from 2021 to 2030.

Global Positive Airway Pressure Devices Market Drivers

Currently, the market is mainly being driven by the growing prevalence of obstructive sleep apnea and chronic respiratory diseases.

Some countries have registered increasing awareness of the benefits of positive airway pressure (PAP) therapy, and as a result, there has been a hike in the prevalence of PAP therapy in those countries in the past few years.

There has been a steady growth in the number of health-tech startups in the industry. The market entry of new players has been further accelerated by the COVID-19 pandemic.

MedTech startups have been responding to the growing demand for ventilators by offering non-invasive unconventional systems and indigenous ventilators. Apart from that, globally, the prevalence of obstructive sleep apnea is expected to exceed 986 million cases by the end of 2026.

According to data obtained from the Global Data Health Exchange and BIS Research analysis, the incidence of the condition in North America was as high as 1 in 11 individuals in 2020. The life expectancy in most countries has surged tremendously.

The improvement in life expectancy is due to significant advancements in diagnostic technology and medical science. Furthermore, growing awareness regarding health, nutrition, and hygiene has also resulted in increased life expectancy.

The prevalence of diseases among the growing geriatric population has grown at a significant pace during 2015-2019 as compared to those aged 54 and below.

Global Positive Airway Pressure Devices Market Challenges

The primary challenge is the lack of awareness of the benefits of positive airway pressure therapy among individuals.

Sleep apnea itself faces a significant challenge in getting diagnosed with many individuals unaware that they suffer from the condition. A key restraining factor to the growth in the adoption of PAP devices is their high cost.

Additionally, the lack of reimbursement policies by the government and commercial payors also hampers the adoption of PAP devices in emerging economies. These devices are also uncomfortable for many users, which results in the discontinuation of therapy.

The global positive airway pressure devices market is also expected to be restrained due to non-adherence.

Global Positive Airway Pressure Devices Market Opportunities

Owing to the rising focus on remote patient monitoring, mobile health applications, and integration of telemedicine in treatment and diagnostic aspects of healthcare, the development of smart PAP devices offers a novel opportunity to both established and emerging players.

Established PAP device manufacturers can develop devices integrated with a mobile application that would enable patients to monitor their breathing quality, sleep quality, and therapy adherence. Moreover, the mobile application could further facilitate data sharing with a physician for patient monitoring.

For instance, Koninklijke Philips N.V. developed DreamMapper, a mobile application compatible with its CPAP devices. The mobile application offers various features such as therapy hours, educational information, progress monitoring, and data sharing with physicians.

Impact of COVID-19 on the Positive Airway Pressure Devices Industry

The impact of COVID-19 varies depending on the region, country, the extent of lockdowns, and the perception of the local population.

The market witnessed a temporary boost in demand when CPAP devices were approved for emergency use by regulatory bodies to bridge the gap between demand for and supply of ventilators.

Key areas of the supply chain were impacted during the initial days of the pandemic, which comprised coinciding lockdowns in several countries leading to a restriction in global logistics. The resulting strain led to reduced stock in warehouses and a hike in logistics costs locally.

Market Segmentation

Global Positive Airway Pressure Devices Market (by Product Type)

CPAPs are considered the gold standard for the treatment of sleep apnea.

The growth in the adoption of CPAP devices across various segments can be attributed to the rise in the prevalence of breathing difficulties, which has led to more doctors prescribing such devices. The history of CPAP therapy can be traced back to the 1950s with the commencement of early sleep studies.

The major challenge associated with recording data in that era was the lack of any digital means to implement CPAP. The use of APAP is mostly restricted to those with moderate-to-severe obstructive sleep apnea (OSA).

The main barriers to the adoption of APAP devices in the market include low diagnosis rates for those suffering from OSA. APAP devices are also priced higher than CPAP devices which are considered the gold standard therapy for OSA.

BiPAP devices have two pressure settings – inhalation PAP and exhalation PAP. Depending on the settings of the device, the switch between inhalation and exhalation can be timed or automatically based on the individual’s breathing patterns.

In some cases, BiPAP devices are considered a better option for some individuals. BiPAPs are priced much higher than CPAP and APAP devices and face low adoption rates.

Global Positive Airway Pressure Devices Market (by Indication)

Sleep apnea is the dominant indication for which positive airway pressure therapy is recommended. Sleep apnea remains undiagnosed among a significant chunk of the individuals who have it. There are several more filters which lead to low adoption rates of positive airway pressure devices.

Global Positive Airway Pressure Devices Market (by End User)

Traditionally, sleep studies were usually conducted at sleep laboratories to monitor physiological data such as heart rate, breathing, and oxygen levels to diagnose sleeping disorders.

However, owing to apprehensions regarding COVID-19 transmission, the pandemic witnessed a decline in the instances of studies conducted at these centers.

The demand created by sleep laboratories is expected to return to normal post the pandemic as patients suffering from severe OSA requiring in-clinic monitoring continue to visit sleep laboratories.

Global Positive Airway Pressure Devices Market (by Region)

The different regions covered under the global positive airway pressure devices market include North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.

North America and Europe are two of the largest markets for positive airway pressure devices, while developing countries are expected to register strong growth in the adoption of positive airway pressure devices in the near future.

Key Market Players and Competition Synopsis

Some of the key players operating in the market include 3B Medical, Inc, Apex Medical Corporation, BMC Medical Co. Ltd., Breas Medical AB, Compumedics Limited, Drive DeVilbiss Healthcare, Elmaslar Group, Fisher & Paykel Healthcare Corporation Limited,

Hebei Topson Medical Technology Co., Ltd., Kare Medical and Analytical Devices Ltd. Co., Koninklijke Philips N.V., Löwenstein Medical Technology GmbH + Co. KG., Narang Medical Limited, ResMed Inc., and Somnetics International, Inc.

Global Urology Care Devices and Platforms Market: Focus on Product Type, Application, Indication, End User, and Regional Analysis

The post Positive Airway Pressure Devices Market – A Global and Regional Analysis: Focus on Product Type, Indication, End User, Epidemiology, Compliance Rate, Discontinuation, and Regional Analysis – Analysis and Forecast, 2021-2030 first appeared on CRI Report.